| Literature DB >> 34786590 |
Sahar Al Shabasy1, Maggie Abbassi1, Aureliano Finch2, Bram Roudijk2, Darrin Baines3, Samar Farid4.
Abstract
INTRODUCTION: No value sets exist for either the EQ-5D-3L or the EQ-5D-5L in Egypt, despite local pharmacoeconomic guidelines recommending the use of the EQ-5D to derive utility. Most published Egyptian economic evaluation studies have used utility values from other published studies and systematic reviews.Entities:
Mesh:
Year: 2021 PMID: 34786590 PMCID: PMC8595057 DOI: 10.1007/s40273-021-01100-y
Source DB: PubMed Journal: Pharmacoeconomics ISSN: 1170-7690 Impact factor: 4.558
Background characteristics of the Egyptian participants
| Characteristics | Full sample ( | Actual sample ( | General populationa | |
|---|---|---|---|---|
| Sex | ||||
| Male | 672 (51.6) | 510 (52.4) | 51.6 | 0.617 |
| Female | 631 (48.4) | 464 (47.6) | 48.4 | 0.617 |
| Age (years) | 35.8 ± 12.8 (18–75) | 36.9 ± 12.7 (18–72) | – | – |
| 18–24 | 317 (24.3) | 213 (21.9) | 18.8 | 0.013* |
| 25–34 | 363 (27.9) | 237 (24.3) | 27.9 | 0.042* |
| 35–44 | 279 (21.4) | 236 (24.2) | 20.9 | 0.003* |
| 45–54 | 212 (16.3) | 184 (18.9) | 15.1 | < 0.001* |
| 55–64 | 110 (8.4) | 90 (9.2) | 10.6 | 0.156 |
| ≥65 | 22 (1.7) | 14 (1.4) | 6.6 | < 0.001* |
| Geographical regionb | ||||
| Greater Cairo | 511 (39.3) | 256 (26.3) | 25.1 | 0.390 |
| Alexandria | 123 (9.5) | 119 (12.2) | 12.4 | 0.849 |
| Delta | 229 (17.6) | 202 (20.8) | 21.7 | 0.497 |
| Suez Canal | 123 (9.5) | 114 (11.7) | 11.2 | 0.624 |
| North upper Egypt | 144 (11.1) | 122 (12.6) | 12.9 | 0.779 |
| Asyut | 45 (3.5) | 44 (4.5) | 4.9 | 0.561 |
| South upper Egypt | 126 (9.7) | 115 (11.8) | 11.8 | 1 |
| Residenceb | ||||
| Urban | 934 (71.8) | 658 (67.7) | 42.2 | < 0.001* |
| Rural | 367 (28.2) | 314 (32.3) | 57.8 | < 0.001* |
| Education levelb | ||||
| Illiterate | 116 (8.9) | 109 (11.2) | 25.8 | < 0.001* |
| Below intermediatec | 311 (23.9) | 290 (29.8) | 29.0 | 0.833 |
| Intermediated | 511 (39.3) | 398 (40.9) | 29.1 | < 0.001* |
| University degree and above | 363 (27.9) | 175 (18) | 15.5 | < 0.001* |
| Employment statusb | ||||
| Employed | 950 (73) | 728 (74.9) | 74.4 | 0.721 |
| Unemployed/retired/students/other | 351 (27) | 244 (25.1) | 25.6 | 0.721 |
| Marital statusb | ||||
| Married | 740 (56.8) | 602 (61.9) | 68 | < 0.001* |
| Single/divorced/widowed | 561 (43.2) | 370 (38.1) | 32 | < 0.001* |
| Religious beliefsb | ||||
| Muslim | 1241 (95.4) | 931 (95.8) | 94.9 e | 0.202 |
| Christian | 60 (4.6) | 41 (4.2) | 5.1 | 0.202 |
| Presence of chronic health conditionb | 414 (31.8) | 285 (29.3) | – | – |
| Health insuranceb | ||||
| Covered (full or partial) | 786 (60.4) | 579 (59.6) | 54.7 | 0.0021* |
| No coverage | 515 (39.6) | 393 (40.4) | 45.3 | 0.0019* |
| VAS-5L scores | 77.5 ± 16.2 | 76.9 ± 16.7 | ||
| Mobility | ||||
| No problems | 893(68.5) | 664 (68.2) | ||
| Slight problems | 234 (18) | 169 (17.4) | ||
| Moderate problems | 136 (10.4) | 107 (11) | ||
| Severe problems | 39 (3) | 34 (3.5) | ||
| Unable to walk | 1 (0.1) | 0 (0) | ||
| Self-care | ||||
| No problems | 1226 (94.1) | 912 (93.6) | ||
| Slight problems | 52 (4) | 40 (4.1) | ||
| Moderate problems | 17 (1.3) | 15 (1.5) | ||
| Severe problems | 8 (0.6) | 7 (0.7) | ||
| Unable to dress and wash | 0(0) | 0 (0) | ||
| Usual activities | ||||
| No problems | 891 (68.4) | 667 (68.5) | ||
| Slight problems | 252 (19.3) | 183 (18.8) | ||
| Moderate problems | 132 (10.1) | 100 (10.3) | ||
| Severe problems | 24 (1.8) | 21 (2.2) | ||
| Unable to do usual activities | 4 (0.3) | 3 (0.3) | ||
| Pain/discomfort | ||||
| No problems | 510 (39.1) | 386 (39.6) | ||
| Slight problems | 436 (33.5) | 302 (31) | ||
| Moderate problems | 284 (21.8) | 219 (22.5) | ||
| Severe problems | 52 (4) | 48 (4.9) | ||
| Extreme pain or discomfort | 21 (1.6) | 19 (2) | ||
| Anxiety/depression | ||||
| No problems | 420 (32.2) | 348 (35.7) | ||
| Slight problems | 410 (31.5) | 287 (29.5) | ||
| Moderate problems | 343 (26.3) | 232 (23.8) | ||
| Severe problems | 76 (5.8) | 61 (6.3) | ||
| Extreme anxiety or depression | 54 (4.1) | 46 (4.7) |
Data are presented as n (%), mean ± standard deviation (range), or % unless otherwise indicated
VAS visual analogue scale
*P < 0.05 (based on 1-sample z-test for a population proportion)
aData estimated from the Egyptian Central Agency for Public Mobilization and Statistics, March 2019 [11]
bSample size was n = 1301 for the full sample and n = 972 for the actual sample
cBelow intermediate: below high school level
dIntermediate: high school level or 2 years institute
eData obtained from Mohamoud et al. [30]
Fig. 1Observed composite time trade-off (cTTO) value distribution
Fig. 2Mean observed composite time trade-off (cTTO) values by level of sum scores. SD standard deviation
Parameter estimates for composite time trade-off models
| Dimension/level | Model 1 | Model 2 | Model 3 | Model 4 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLS (random-effect model) | GLS Tobit (random effect, censored at − 1) | Heteroskedastic Tobit (censored at − 1 with correction for heteroskedasticity) | Heteroskedastic model (constrained, heteroskedasticity of the error term, constant suppressed) (value set) | |||||||||
| Coeff. | SE | Coeff. | SE | Coeff. | SE | Coeff. | SE | |||||
| MO | ||||||||||||
| Disutility MO1–MO2 | 0.084 | 0.015 | 0.000 | 0.068 | 0.016 | 0.000 | 0.033 | 0.012 | 0.007 | 0.074 | 0.013 | 0.000 |
| Disutility MO1–MO3 | 0.202 | 0.016 | 0.000 | 0.171 | 0.017 | 0.000 | 0.107 | 0.021 | 0.000 | 0.208 | 0.02 | 0.000 |
| Disutility MO1–MO4 | 0.409 | 0.017 | 0.000 | 0.386 | 0.019 | 0.000 | 0.334 | 0.022 | 0.000 | 0.401 | 0.02 | 0.000 |
| Disutility MO1–MO5 | 0.618 | 0.016 | 0.000 | 0.659 | 0.017 | 0.000 | 0.699 | 0.02 | 0.000 | 0.604 | 0.017 | 0.000 |
| SC | ||||||||||||
| Disutility SC1–SC2 | 0.031 | 0.015 | 0.034 | 0.029 | 0.016 | 0.026 | 0.011 | 0.021 | 0.053 | 0.011 | 0.000 | |
| Disutility SC1–SC3 | 0.106 | 0.017 | 0.000 | 0.105 | 0.018 | 0.000 | 0.098 | 0.018 | 0.000 | 0.106 | 0.018 | 0.000 |
| Disutility SC1–SC4 | 0.243 | 0.017 | 0.000 | 0.241 | 0.018 | 0.000 | 0.236 | 0.020 | 0.000 | 0.248 | 0.019 | 0.000 |
| Disutility SC1–SC5 | 0.253 | 0.015 | 0.000 | 0.316 | 0.017 | 0.000 | 0.429 | 0.019 | 0.000 | 0.283 | 0.016 | 0.000 |
| UA | ||||||||||||
| Disutility UA1–UA2 | 0.045 | 0.015 | 0.003 | 0.04 | 0.016 | 0.016 | 0.025 | 0.011 | 0.025 | 0.052 | 0.011 | 0.000 |
| Disutility UA1–UA3 | 0.075 | 0.016 | 0.000 | 0.072 | 0.018 | 0.000 | 0.074 | 0.018 | 0.000 | 0.078 | 0.018 | 0.000 |
| Disutility UA1–UA4 | 0.221 | 0.016 | 0.000 | 0.22 | 0.018 | 0.000 | 0.234 | 0.019 | 0.000 | 0.23 | 0.014 | 0.000 |
| Disutility UA1–UA5 | 0.24 | 0.015 | 0.000 | 0.299 | 0.017 | 0.000 | 0.371 | 0.021 | 0.000 | 0.23 | 0.014 | 0.000 |
| PD | ||||||||||||
| Disutility PD1–PD2 | 0.045 | 0.014 | 0.001 | 0.033 | 0.015 | 0.026 | 0.028 | 0.010 | 0.007 | 0.054 | 0.01 | 0.000 |
| Disutility PD1–PD3 | 0.076 | 0.017 | 0.000 | 0.071 | 0.018 | 0.000 | 0.062 | 0.021 | 0.003 | 0.106 | 0.02 | 0.000 |
| Disutility PD1–PD4 | 0.244 | 0.015 | 0.000 | 0.261 | 0.016 | 0.000 | 0.29 | 0.019 | 0.000 | 0.274 | 0.018 | 0.000 |
| Disutility PD1–PD5 | 0.363 | 0.016 | 0.000 | 0.412 | 0.018 | 0.000 | 0.499 | 0.022 | 0.000 | 0.434 | 0.018 | 0.000 |
| AD | ||||||||||||
| Disutility AD1–AD2 | 0.048 | 0.016 | 0.002 | 0.041 | 0.017 | 0.018 | 0.038 | 0.01 | 0.000 | 0.054 | 0.01 | 0.000 |
| Disutility AD1–AD3 | 0.158 | 0.018 | 0.000 | 0.139 | 0.02 | 0.000 | 0.14 | 0.021 | 0.000 | 0.181 | 0.019 | 0.000 |
| Disutility AD1–AD4 | 0.298 | 0.016 | 0.000 | 0.296 | 0.018 | 0.000 | 0.323 | 0.019 | 0.000 | 0.331 | 0.018 | 0.000 |
| Disutility AD1–AD5 | 0.4 | 0.015 | 0.000 | 0.444 | 0.017 | 0.000 | 0.527 | 0.018 | 0.000 | 0.413 | 0.016 | 0.000 |
| Constant | 0.037 | 0.018 | 0.037 | 0.037 | 0.02 | 0.064 | 0.016 | 0.011 | 0.122 | – | – | – |
| Dimension ranking | MO-AD-PD-SC-UA | MO-AD-PD-SC-UA | MO-AD-PD-SC-UA | MO-PD-AD-SC-UA | ||||||||
| Insignificant | 0 | 1 | 0 | 0 | ||||||||
| Illogically ordered | 0 | 0 | 0 | 0 | ||||||||
| AIC | 10282.88 | 12203.67 | 12419.71 | 11206.28 | ||||||||
| BIC | 10445.88 | 12366.68 | 12717.38 | 11482.69 | ||||||||
| MAE | 0.3638 | 0.374 | 0.410 | 0.3595 | ||||||||
| RMSE | 0.482 | 0.491 | 0.536 | 0.483 | ||||||||
| 55555 | − 0.911 | − 1.167 | − 1.541 | − 0.964 | ||||||||
AD anxiety/depression, AIC Akaike information criterion, BIC Bayesian information criterion, Coeff coefficient, GLS generalized least square, MAE mean absolute error, MO mobility, PD pain/discomfort, RMSE root mean square error, SC self-care, SE standard error, UA usual activities. Bold P value is not significant
Parameter estimates for discrete-choice experiment model
| Dimension/level | Model 5 | |||
|---|---|---|---|---|
| Conditional logit model | ||||
| Beta | Rescaled Beta | SE | ||
| MO | ||||
| Disutility MO1–MO2 | 0.266 | 0.069 | 0.058 | 0.000 |
| Disutility MO1–MO3 | 0.36 | 0.093 | 0.067 | 0.000 |
| Disutility MO1–MO4 | 1.13 | 0.291 | 0.072 | 0.000 |
| Disutility MO1–MO5 | 2.28 | 0.587 | 0.09 | 0.000 |
| SC | ||||
| Disutility SC1–SC2 | 0.241 | 0.062 | 0.065 | 0.000 |
| Disutility SC1–SC3 | 0.237 | 0.061 | 0.069 | 0.001 |
| Disutility SC1–SC4 | 0.783 | 0.202 | 0.071 | 0.000 |
| Disutility SC1–SC5 | 1.5 | 0.386 | 0.074 | 0.000 |
| UA | ||||
| Disutility UA1–UA2 | 0.277 | 0.071 | 0.06 | 0.000 |
| Disutility UA1–UA3 | 0.261 | 0.067 | 0.069 | 0.000 |
| Disutility UA1–UA4 | 0.837 | 0.215 | 0.07 | 0.000 |
| Disutility UA1–UA5 | 1.548 | 0.399 | 0.076 | 0.000 |
| PD | ||||
| Disutility PD1–PD2 | 0.18 | 0.046 | 0.064 | 0.005 |
| Disutility PD1–PD3 | 0.273 | 0.07 | 0.069 | 0.000 |
| Disutility PD1–PD4 | 0.734 | 0.189 | 0.069 | 0.000 |
| Disutility PD1–PD5 | 1.435 | 0.369 | 0.075 | 0.000 |
| AD | ||||
| Disutility AD1–AD2 | 0.08 | 0.02 | 0.065 | |
| Disutility AD1–AD3 | 0.25 | 0.064 | 0.067 | 0.000 |
| Disutility AD1–AD4 | 0.823 | 0.212 | 0.074 | 0.000 |
| Disutility AD1–AD5 | 1.529 | 0.394 | 0.082 | 0.000 |
| Dimension ranking | MO-UA-AD-SC-PD | |||
| Insignificant | 1 | |||
| Illogically ordered | 2 | |||
| AIC | 6776.675 | |||
| BIC | 6913.222 | |||
| 55555 | − 1.135 | |||
AD anxiety/depression, AIC Akaike information criterion, BIC Bayesian information criterion, MO mobility, PD pain/discomfort, SC self-care, SE standard error, UA usual activities. Bold P value is not significant
Parameter estimates for hybrid models
| Dimension/level | Model 6 | Model 7 | Model 8 | Model 9 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hybrid (conditional logit model) | Hybrid Tobit (censored at − 1, conditional logit model) | Hybrid heteroskedastic Tobit (censored at − 1 with heteroskedasticity, conditional logit model) | Hybrid heteroskedastic model heteroskedasticity, conditional logit model) | |||||||||
| Coeff. | SE | Coeff. | SE | Coeff. | SE | Coeff. | SE | |||||
| MO | ||||||||||||
| Disutility MO1-MO2 | 0.1 | 0.011 | 0.000 | 0.089 | 0.012 | 0.000 | 0.055 | 0.009 | 0.000 | 0.085 | 0.009 | 0.000 |
| Disutility MO1-MO3 | 0.142 | 0.012 | 0.000 | 0.126 | 0.013 | 0.000 | 0.104 | 0.014 | 0.000 | 0.139 | 0.012 | 0.000 |
| Disutility MO1-MO4 | 0.348 | 0.012 | 0.000 | 0.34 | 0.013 | 0.000 | 0.342 | 0.014 | 0.000 | 0.341 | 0.012 | 0.000 |
| Disutility MO1-MO5 | 0.583 | 0.012 | 0.000 | 0.621 | 0.013 | 0.000 | 0.709 | 0.014 | 0.000 | 0.586 | 0.012 | 0.000 |
| SC | ||||||||||||
| Disutility SC1-SC2 | 0.063 | 0.011 | 0.000 | 0.06 | 0.012 | 0.000 | 0.045 | 0.008 | 0.000 | 0.062 | 0.009 | 0.000 |
| Disutility SC1-SC3 | 0.09 | 0.012 | 0.000 | 0.081 | 0.013 | 0.000 | 0.082 | 0.013 | 0.000 | 0.089 | 0.012 | 0.000 |
| Disutility SC1-SC4 | 0.245 | 0.012 | 0.000 | 0.238 | 0.013 | 0.000 | 0.242 | 0.014 | 0.000 | 0.242 | 0.012 | 0.000 |
| Disutility SC1-SC5 | 0.333 | 0.011 | 0.000 | 0.38 | 0.012 | 0.000 | 0.456 | 0.013 | 0.000 | 0.349 | 0.011 | 0.000 |
| UA | ||||||||||||
| Disutility UA1-UA2 | 0.082 | 0.011 | 0.000 | 0.076 | 0.012 | 0.000 | 0.045 | 0.008 | 0.000 | 0.065 | 0.009 | 0.000 |
| Disutility UA1-UA3 | 0.095 | 0.012 | 0.000 | 0.092 | 0.013 | 0.000 | 0.073 | 0.013 | 0.000 | 0.092 | 0.012 | 0.000 |
| Disutility UA1-UA4 | 0.236 | 0.012 | 0.000 | 0.244 | 0.013 | 0.000 | 0.247 | 0.013 | 0.000 | 0.239 | 0.012 | 0.000 |
| Disutility UA1-UA5 | 0.342 | 0.011 | 0.000 | 0.395 | 0.012 | 0.000 | 0.442 | 0.013 | 0.000 | 0.337 | 0.011 | 0.000 |
| PD | ||||||||||||
| Disutility PD1-PD2 | 0.059 | 0.011 | 0.000 | 0.052 | 0.011 | 0.000 | 0.039 | 0.008 | 0.000 | 0.054 | 0.008 | 0.000 |
| Disutility PD1-PD3 | 0.087 | 0.012 | 0.000 | 0.087 | 0.013 | 0.000 | 0.077 | 0.014 | 0.000 | 0.103 | 0.012 | 0.000 |
| Disutility PD1-PD4 | 0.23 | 0.012 | 0.000 | 0.244 | 0.013 | 0.000 | 0.263 | 0.014 | 0.000 | 0.239 | 0.012 | 0.000 |
| Disutility PD1-PD5 | 0.341 | 0.012 | 0.000 | 0.396 | 0.013 | 0.000 | 0.475 | 0.015 | 0.000 | 0.37 | 0.012 | 0.000 |
| AD | ||||||||||||
| Disutility AD1-AD2 | 0.06 | 0.011 | 0.000 | 0.059 | 0.012 | 0.000 | 0.042 | 0.007 | 0.000 | 0.055 | 0.008 | 0.000 |
| Disutility AD1-AD3 | 0.137 | 0.012 | 0.000 | 0.125 | 0.013 | 0.000 | 0.114 | 0.014 | 0.000 | 0.133 | 0.012 | 0.000 |
| Disutility AD1-AD4 | 0.267 | 0.012 | 0.000 | 0.282 | 0.012 | 0.000 | 0.293 | 0.013 | 0.000 | 0.276 | 0.011 | 0.000 |
| Disutility AD1-AD5 | 0.395 | 0.012 | 0.000 | 0.436 | 0.012 | 0.000 | 0.507 | 0.014 | 0.000 | 0.399 | 0.011 | 0.000 |
| Constant | 0.005 | 0.007 | 0.474 | – | – | – | – | – | – | – | – | – |
| Dimension ranking | MO-AD-UA-PD-SC | MO-AD-PD-UA-SC | MO-AD-PD-SC-UA | MO-AD-PD-SC-UA | ||||||||
| Insignificant | 0 | 0 | 0 | 0 | ||||||||
| Illogically ordered | 0 | 0 | 0 | 0 | ||||||||
| AIC | 19232.64 | 21297.46 | 19207.84 | 18103.23 | ||||||||
| BIC | 19401.14 | 21465.95 | 19529.51 | 18424.9 | ||||||||
| MAE | 0.362216 | 0.382768 | 0.416236 | 0.363773 | ||||||||
| RMSE | 0.485575 | 0.497105 | 0.543049 | 0.486582 | ||||||||
| 55555 | − 0.999 | − 1.228 | − 1.589 | − 1.041 | ||||||||
AD anxiety/depression, AIC Akaike information criterion, BIC Bayesian information criterion, Coeff coefficient, MAE mean absolute error, MO mobility, PD pain/discomfort, RMSE root mean square error, SC self-care, SE standard error, UA usual activities
Fig. 3Scatterplots of the predicted values of the heteroskedastic model with constraints versus the mean observed values of composite time trade-off (cTTO) of each health state
| This is the first EQ-5D-5L valuation study in Egypt and the Middle East and North Africa region. |
| The Egyptian tariff can be used as a scoring system for economic evaluations, to inform decision making, and to improve the quality of health technology assessment in the Egyptian healthcare system. |
| The availability of the Egyptian tariff will encourage health economists and clinicians to include quality-of-life questionnaires in clinical trials and implement cost-utility analysis and pharmacoeconomic modelling. |